• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies.miR-146a 缺陷型小鼠中 NF-κB 的失调导致髓系恶性肿瘤的发生。
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9184-9. doi: 10.1073/pnas.1105398108. Epub 2011 May 16.
2
Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo.髓系细胞靶向 miR-146a 模拟物抑制体内 NF-κB 驱动的炎症和白血病进展。
Blood. 2020 Jan 16;135(3):167-180. doi: 10.1182/blood.2019002045.
3
An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses.一个核因子-κB-微小RNA调控网络调节巨噬细胞炎症反应。
Nat Commun. 2017 Oct 11;8(1):851. doi: 10.1038/s41467-017-00972-z.
4
Ablation of miR-146b in mice causes hematopoietic malignancy.在小鼠中敲除 miR-146b 导致造血系统恶性肿瘤。
Blood Adv. 2018 Dec 11;2(23):3483-3491. doi: 10.1182/bloodadvances.2018017954.
5
MicroRNA-146a modulates B-cell oncogenesis by regulating Egr1.微小RNA-146a通过调节早期生长反应蛋白1来调控B细胞肿瘤发生。
Oncotarget. 2015 May 10;6(13):11023-37. doi: 10.18632/oncotarget.3433.
6
Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis.载脂蛋白E增强单核细胞和巨噬细胞中的微小RNA-146a,以抑制核因子-κB驱动的炎症和动脉粥样硬化。
Circ Res. 2015 Jun 19;117(1):e1-e11. doi: 10.1161/CIRCRESAHA.117.305844. Epub 2015 Apr 22.
7
MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice.微小RNA-146a在小鼠中作为造血干细胞质量和寿命的守护者。
Elife. 2013 May 21;2:e00537. doi: 10.7554/eLife.00537.
8
microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer.microRNA-146a 通过靶向胃癌中的 CARD10 和 COPS8 抑制 G 蛋白偶联受体介导的 NF-κB 激活。
Mol Cancer. 2012 Sep 20;11:71. doi: 10.1186/1476-4598-11-71.
9
Myeloid cells control termination of lung inflammation through the NF-kappaB pathway.髓样细胞通过NF-κB信号通路控制肺部炎症的消退。
Am J Physiol Lung Cell Mol Physiol. 2009 Mar;296(3):L320-7. doi: 10.1152/ajplung.90485.2008. Epub 2008 Dec 19.
10
Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-κB-dependent manner.骨髓微环境中Notch依赖的miR-155抑制以NF-κB依赖的方式调节造血作用。
Cell Stem Cell. 2014 Jul 3;15(1):51-65. doi: 10.1016/j.stem.2014.04.021.

引用本文的文献

1
Inflammatory signaling in the pathogenesis of acute myeloid leukemia.急性髓系白血病发病机制中的炎症信号传导
Hemasphere. 2025 Aug 13;9(8):e70188. doi: 10.1002/hem3.70188. eCollection 2025 Aug.
2
A Multimodal Therapeutic Strategy for Inflammatory Bowel Disease Using MicroRNA-146a Mimic Encapsulated in Lipid Nanoparticles.一种使用包裹在脂质纳米颗粒中的微小RNA-146a模拟物治疗炎症性肠病的多模式治疗策略。
Mol Pharm. 2025 Jun 2;22(6):3132-3141. doi: 10.1021/acs.molpharmaceut.5c00014. Epub 2025 May 5.
3
Mechanisms underlying TRPV4-mediated regulation of miR-146a expression.TRPV4 介导热激蛋白 146a 表达调控的机制。
Front Immunol. 2024 Sep 30;15:1437540. doi: 10.3389/fimmu.2024.1437540. eCollection 2024.
4
Non-coding RNA and its network in the pathogenesis of Myasthenia Gravis.非编码RNA及其网络在重症肌无力发病机制中的作用
Front Mol Biosci. 2024 Sep 10;11:1388476. doi: 10.3389/fmolb.2024.1388476. eCollection 2024.
5
MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response.骨髓增生异常综合征中的微小RNA失调:对诊断、预后及治疗反应的影响
Front Oncol. 2024 Aug 2;14:1410656. doi: 10.3389/fonc.2024.1410656. eCollection 2024.
6
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML.失调的先天免疫信号传导与RUNX1突变协同作用,将类似骨髓增生异常综合征的疾病转化为急性髓系白血病。
iScience. 2024 Apr 24;27(6):109809. doi: 10.1016/j.isci.2024.109809. eCollection 2024 Jun 21.
7
CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response.CLPs-miR-103a-2-5p 通过靶向 LILRB3 和 Nrf2/HO-1 轴,调节 CD8+T 细胞反应,抑制 AML 细胞增殖并促进细胞凋亡。
J Transl Med. 2024 Mar 14;22(1):278. doi: 10.1186/s12967-024-05070-5.
8
In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms.体内消融 NF-κB 级联效应物可减轻骨髓增殖性肿瘤的疾病负担。
Blood. 2024 Jun 6;143(23):2414-2424. doi: 10.1182/blood.2023022804.
9
MiRNA-146a-A Key Player in Immunity and Diseases.miRNA-146a:免疫与疾病中的关键分子
Int J Mol Sci. 2023 Aug 14;24(16):12767. doi: 10.3390/ijms241612767.
10
Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation.在炎症期间,p53 的失活为 del(5q) 骨髓增生异常综合征造血干细胞提供了竞争优势。
Haematologica. 2023 Oct 1;108(10):2715-2729. doi: 10.3324/haematol.2022.282349.

本文引用的文献

1
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.miR-146a 是小鼠自身免疫、骨髓增生和癌症的重要制动因素。
J Exp Med. 2011 Jun 6;208(6):1189-201. doi: 10.1084/jem.20101823. Epub 2011 May 9.
2
Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.miR-146a 在调控 Treg 细胞介导的 Th1 反应中的作用。
Cell. 2010 Sep 17;142(6):914-29. doi: 10.1016/j.cell.2010.08.012.
3
MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.MicroRNA-34a 通过抑制叉头框转录因子 Foxp1 扰乱 B 淋巴细胞发育。
Immunity. 2010 Jul 23;33(1):48-59. doi: 10.1016/j.immuni.2010.06.013. Epub 2010 Jul 1.
4
Immunity, inflammation, and cancer.免疫、炎症与癌症。
Cell. 2010 Mar 19;140(6):883-99. doi: 10.1016/j.cell.2010.01.025.
5
Physiological and pathological roles for microRNAs in the immune system.miRNAs 在免疫系统中的生理和病理作用。
Nat Rev Immunol. 2010 Feb;10(2):111-22. doi: 10.1038/nri2708.
6
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.鉴定 miR-145 和 miR-146a 作为 5q-综合征表型的介质。
Nat Med. 2010 Jan;16(1):49-58. doi: 10.1038/nm.2054. Epub 2009 Nov 8.
7
MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.微小RNA-146a通过靶向肿瘤坏死因子受体相关因子6(TRAF6)、白细胞介素-1受体相关激酶1(IRAK1)和白细胞介素-1受体相关激酶2(IRAK2),反馈抑制巨噬细胞中视黄酸诱导基因I(RIG-I)依赖性I型干扰素的产生。
J Immunol. 2009 Aug 1;183(3):2150-8. doi: 10.4049/jimmunol.0900707. Epub 2009 Jul 13.
8
NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy.核因子κB信号传导在致癌作用中的作用以及作为癌症治疗的潜在分子靶点。
Apoptosis. 2009 Apr;14(4):348-63. doi: 10.1007/s10495-009-0315-0.
9
MicroRNAs: target recognition and regulatory functions.微小RNA:靶标识别与调控功能
Cell. 2009 Jan 23;136(2):215-33. doi: 10.1016/j.cell.2009.01.002.
10
MicroRNA control in the immune system: basic principles.免疫系统中的微小RNA调控:基本原理
Cell. 2009 Jan 9;136(1):26-36. doi: 10.1016/j.cell.2008.12.027.

miR-146a 缺陷型小鼠中 NF-κB 的失调导致髓系恶性肿瘤的发生。

NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies.

机构信息

Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 May 31;108(22):9184-9. doi: 10.1073/pnas.1105398108. Epub 2011 May 16.

DOI:10.1073/pnas.1105398108
PMID:21576471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3107319/
Abstract

MicroRNA miR-146a has been implicated as a negative feedback regulator of NF-κB activation. Knockout of the miR-146a gene in C57BL/6 mice leads to histologically and immunophenotypically defined myeloid sarcomas and some lymphomas. The sarcomas are transplantable to immunologically compromised hosts, showing that they are true malignancies. The animals also exhibit chronic myeloproliferation in their bone marrow. Spleen and marrow cells show increased transcription of NF-κB-regulated genes and tumors have higher nuclear p65. Genetic ablation of NF-κB p50 suppresses the myeloproliferation, showing that dysregulation of NF-κB is responsible for the myeloproliferative disease.

摘要

miR-146a 是 NF-κB 激活的负反馈调节因子。在 C57BL/6 小鼠中敲除 miR-146a 基因,会导致组织学和免疫表型定义明确的髓肉瘤和一些淋巴瘤。肉瘤可移植到免疫功能受损的宿主中,表明它们是真正的恶性肿瘤。动物的骨髓中还表现出慢性骨髓增生。脾脏和骨髓细胞显示 NF-κB 调节基因的转录增加,肿瘤细胞核中 p65 升高。NF-κB p50 的遗传缺失抑制骨髓增生,表明 NF-κB 的失调是骨髓增生性疾病的原因。